ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 138,040 | 137,430 | 131,654 | 131,829 | 116,547 |
Cost of Goods | 57,698 | 49,157 | 53,420 | 48,101 | 42,284 |
Gross Profit | 80,342 | 88,273 | 78,234 | 83,728 | 74,263 |
Operating Expenses | 75,871 | 68,118 | 71,928 | 65,881 | 62,145 |
Operating Income | 5,169 | 20,312 | 6,726 | 17,948 | 12,402 |
Interest Expense | 4,656 | 4,600 | 5,746 | 6,398 | 7,100 |
Other Income | -2,800 | 9,623 | -33 | -39 | -53 |
Pre-tax Income | -2,287 | 25,335 | 947 | 11,511 | 5,249 |
Income Tax | N/A | 7,128 | -208 | 1,571 | -996 |
Net Income Continuous | -2,287 | 18,207 | 1,155 | 9,940 | 6,245 |
Net Income | $-2,287 | $18,207 | $1,155 | $9,940 | $6,245 |
EPS Basic Total Ops | -0.14 | 0.84 | 0.04 | 0.46 | 0.30 |
EPS Basic Continuous Ops | -0.12 | 0.95 | 0.08 | 0.53 | 0.35 |
EPS Diluted Total Ops | -0.14 | 0.82 | 0.05 | 0.45 | 0.29 |
EPS Diluted Continuous Ops | -0.12 | 0.94 | 0.08 | 0.52 | 0.35 |
EPS Diluted Before Non-Recurring Items | 0.72 | 0.95 | 0.78 | 1.05 | 1.06 |
EBITDA(a) | $19,866 | $34,998 | $21,920 | $33,155 | $27,092 |